Your browser doesn't support javascript.
loading
Comment on "Consolidation Osimertinib Versus Durvalumab following Concurrent Chemoradiation in Unresectable EGFR-Mutant NSCLC".
Chen, Ching-Yi; Wang, Guo-Sheng; Wei, James Cheng-Chung.
Afiliação
  • Chen CY; Division of Chest Medicine, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung, Taiwan.
  • Wang GS; Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China.
  • Wei JC; Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Nursing, Chung Shan Medical University, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan. Electronic address: jccwei@gmail.com.
J Thorac Oncol ; 19(5): e6-e7, 2024 May.
Article em En | MEDLINE | ID: mdl-38719427
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Quimiorradioterapia / Receptores ErbB / Compostos de Anilina / Neoplasias Pulmonares / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Carcinoma Pulmonar de Células não Pequenas / Quimiorradioterapia / Receptores ErbB / Compostos de Anilina / Neoplasias Pulmonares / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2024 Tipo de documento: Article